PapersFlow Research Brief
Liver Disease and Transplantation
Research Guide
What is Liver Disease and Transplantation?
Liver disease and transplantation encompasses the spectrum of chronic and acute hepatic disorders leading to organ failure, managed through medical interventions or orthotopic liver replacement using donor organs to restore function.
The field includes over 109,376 published works addressing diagnosis, management, and surgical replacement of diseased livers. High-impact studies cover emergency interventions for variceal bleeding, transplantation outcomes for hepatocellular carcinoma, and guidelines for nonalcoholic fatty liver disease. Research emphasizes predictive models like the MELD score for prioritizing end-stage patients.
Research Sub-Topics
Non-alcoholic Fatty Liver Disease
Non-alcoholic Fatty Liver Disease (NAFLD) research covers epidemiology, pathophysiology from steatosis to NASH, and metabolic risk factors. Researchers study diagnostic biomarkers, progression models, and lifestyle interventions.
Hepatocellular Carcinoma Management
Hepatocellular Carcinoma (HCC) studies address surveillance, locoregional therapies, systemic treatments, and outcomes in cirrhosis. Researchers evaluate guidelines, sorafenib efficacy, and immunotherapy advances.
Liver Transplantation Outcomes
Liver Transplantation research examines MELD scoring, graft survival, rejection mechanisms, and post-transplant complications. Researchers analyze donor-recipient matching and immunosuppression protocols.
Gut-Liver Axis in Cirrhosis
Gut-Liver Axis investigations link intestinal dysbiosis, endotoxemia, and portal hypertension in cirrhosis. Researchers explore microbiota modulation, bacterial translocation, and systemic inflammation.
Noninvasive Fibrosis Assessment
Noninvasive Fibrosis Assessment develops biomarkers, elastography, and scores like FIB-4 for staging liver fibrosis without biopsy. Researchers validate tools in viral hepatitis, NAFLD, and HIV coinfection.
Why It Matters
Liver transplantation treats small hepatocellular carcinomas in cirrhotic patients, as Mazzaferro et al. (1996) demonstrated effective outcomes in "Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis" with 7045 citations. Practice guidelines by Chalasani et al. (2017) in "The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases" provide data-supported approaches to NAFLD diagnosis and prevention, impacting over 7017 citations in clinical care. The MELD model by Kamath et al. (2001) in "A Model to Predict Survival in Patients With End–Stage Liver Disease" predicts survival to allocate organs, cited 4837 times and used globally for waitlist prioritization. Recent ARPA-H awards up to $28.5 million to Carnegie Mellon develop 3D bioprinted livers for acute failure, addressing organ shortages.
Reading Guide
Where to Start
"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases" by Chalasani et al. (2017), as it offers a data-supported overview of a prevalent liver disease with diagnostic and preventive strategies accessible to newcomers.
Key Papers Explained
Pugh et al. (1973) in "Transection of the oesophagus for bleeding oesophageal varices" established emergency management for variceal bleeding (7858 citations), foundational for stabilizing cirrhosis patients before transplantation. Mazzaferro et al. (1996) advanced curative options in "Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis" (7045 citations) by validating transplant for early HCC. Kamath et al. (2001) provided the MELD score in "A Model to Predict Survival in Patients With End–Stage Liver Disease" (4837 citations) to prioritize allocation, building on prior works for equitable organ distribution.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Recent preprints discuss controversies like LDLT requirements in pediatric programs (Galvan et al., 2025) and advances in donor selection, immunosuppression, and preservation (2025 preprint). ARPA-H-funded projects at Carnegie Mellon and others target 3D bioprinted livers for trials within five years, alongside liver xenotransplantation via ex vivo perfusion.
Papers at a Glance
In the News
Columbia University and Partners Awarded Up to $25M to ...
Columbia University is part of a team led by the Wyss Institute at Harvard University that has received an up to five-year, $25 million award from the Advanced Research Projects Agency for Health (...
ARPA-H awards teams set to bioprint universally matched ...
* **Carnegie Mellon University**in Pittsburgh aims to create a cost-effective immune-silent bioprinted liver that is ready for first-in-human trials in five years. The team will produce human-sized...
Carnegie Mellon awarded ARPA-H contract to develop 3D bioprinted liver
A Carnegie Mellon University-led team has received up to $28.5 million to develop a functional, 3D bioprinted liver for patients with acute liver failure. The temporary, immune-compatible liver is ...
ARPA-H project aims to end liver transplant shortage with 3D bioprinting
California San Diego, funded by the Advanced Research Projects Agency for Health (ARPA-H), aims to change that by developing a fully functional, patient-specific, 3D bioprinted liver.**
UTSW receives ARPA-H award to create functioning ...
This publication was supported by the Advanced Research Projects Agency for Health (ARPA-H) under Award Number D25AC000239-00, providing up to $24,939,120 for a 60-month period. The content is sole...
Code & Tools
This repository contains an AI-driven Liver Transplant Committee Decision System that evaluates patient eligibility for liver transplantation. The ...
This repository contains the code and relevant documentation for the development of the MASLD treatment modelling. This modelling is intended to pr...
audit and clinical research in solid organ transplantation. These are particularly intended to work well with multiple datapoints in large series o...
## Repository files navigation # ameld A dataset of patients evaluated for liver transplantation at the University Hospital Leipzig from November...
Code ## Folders and files
Recent Preprints
Latest Articles : Liver Transplantation
ACCEPTED MS Controversies in Liver Transplantation Corner CON: LDLT should not be a requirement for pediatric transplant programs Galvan, N. ...
Liver Transplantation
- Editorials - Original Articles: Liver Failure and Portal Hypertension - Original Articles: Waitlist Outcomes and Organ Allocation - Original Articles: Hepatobiliary Malignancies and Transplant...
Advances in Liver Transplantation: Clinical Outcomes, Immunological Challenges, and Innovations in Donor Selection and Organ Preservation Techniques
and select hepatic malignancies. Over the last decade, tremendous advancements have been made in donor selection, immunosuppressive strategies, and organ preservation technologies. This paper rev...
Immunocompatibility in transplantation: adapting to a ...
*Liver*|–|++|+|Rejection|The liver is immunologically privileged, so HLA matching plays a minimal role in most cases. ABO compatibility is far more critical.| *Lung*|–|–|++|Rejection, CLAD, BOS|HLA...
Transplantation - Latest research and news
Liver xenotransplantation and genetically engineered pig livers have potential to save human lives. Liver xenotransplants can either act as a bridge to allotransplantation or support the recovery a...
Latest Developments
Recent developments in liver disease and transplantation research include advancements in noninvasive diagnostics, fibrosis staging, and therapeutic targets for steatotic liver diseases such as MASLD and MetALD, highlighted at the 2026 Emerging Topic Conference (aasld.org). Additionally, breakthroughs in bioprinted liver tissue aim to provide temporary support for patients with acute liver failure (good.is, last Friday), along with ongoing research into gene-edited pig liver xenotransplantation showing promising results (nature.com, April 14, 2025). Furthermore, a comprehensive 23-year analysis of over 4,000 liver transplants in Turkey highlights the high volume of living donor procedures (mdpi.com, January 2026).
Sources
Frequently Asked Questions
What technique did Pugh et al. use for bleeding esophageal varices?
Pugh et al. (1973) performed emergency ligation using the Milnes Walker technique in 38 patients, as detailed in "Transection of the oesophagus for bleeding oesophageal varices". Haemorrhage continued or recurred in 11 patients, all of whom died, while 10 others died from hepatic failure post-operation.
How does liver transplantation treat hepatocellular carcinoma?
Mazzaferro et al. (1996) showed liver transplantation is effective for small, unresectable hepatocellular carcinomas in cirrhosis patients in "Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis". The approach addresses both tumor and underlying liver disease simultaneously.
What is the MELD score used for in liver disease?
Kamath et al. (2001) developed the MELD model to predict survival in end-stage liver disease patients in "A Model to Predict Survival in Patients With End–Stage Liver Disease". It uses generalizable variables to prioritize organ allocation for transplantation.
What changes occur in intestinal functions during liver cirrhosis?
Fukui and Wiest (2016) reviewed gut-liver axis alterations central to cirrhosis management in "Changes of Intestinal Functions in Liver Cirrhosis". These include dysbiosis and permeability changes contributing to complications.
What do AASLD guidelines recommend for hepatocellular carcinoma?
Heimbach et al. (2017) outlined treatments including transplantation in "AASLD guidelines for the treatment of hepatocellular carcinoma". The guidelines address staging, resection, ablation, and transplant eligibility.
Open Research Questions
- ? How can donor selection and organ preservation techniques improve long-term graft survival in liver transplantation?
- ? What immunological factors explain the liver's tolerance to HLA mismatch compared to other organs?
- ? Can xenotransplantation with genetically engineered pig livers serve as a bridge to human allotransplantation?
- ? How do bioprinted livers address shortages in acute liver failure cases?
- ? What role do gut-liver axis changes play in predicting decompensation in cirrhosis?
Recent Trends
ARPA-H awarded up to $28.5 million to Carnegie Mellon for 3D bioprinted livers supporting regeneration in acute failure (2026 news).
Preprints highlight LDLT debates in pediatrics (Galvan et al., 2025) and immunological privileges of liver grafts minimizing HLA needs.
Xenotransplantation with pig livers emerges for bridging acute failure, per 2025-11 news.
Research Liver Disease and Transplantation with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching Liver Disease and Transplantation with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.